Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic.

Nancy Herrera-LeañoJulián Esteban Barahona-CorreaOscar Muñoz-VelandiaDaniel G Fernández-ÁvilaAlejandro Mariño-CorreaÁngel Alberto García

Published in: Therapeutic advances in cardiovascular disease (2023)

In patients with advanced HF on intermittent inotropic therapy, a high DE efficiency is associated with a higher risk of mortality or HF hospitalization in a 12-month follow-up period.

Keyphrases

acute heart failure
heart failure
left ventricular
primary care
high dose
cardiovascular events
risk factors
high intensity
stem cells
type diabetes
low dose
coronary artery disease